EMCURE price chart
Daily close · 5-year history
Instrument details
Identifiers & classification
- Symbol
- EMCURE
- MB Code
- MBEQU3784
- ISIN
- INE168P01015
- BSE code
- 544210
- Industry group
- Pharmaceuticals & Biotechnology
- Screener
- View peers →
Latest earnings
Most recent declared quarter
- Quarter
- Mar 2026
- Revenue
- 2469.7 Cr
- Net profit
- 243.74 Cr
- EPS
- 12.84
- YoY revenue
- +16.70%
Company documents
10 PDFs across 4 categories
Audited annual reports & financial statements
Earnings call transcripts & Q&A
Investor decks & strategy updates
Exchange filings & corporate announcements
Corporate timeline
Earnings, news & corporate actions for EMCURE
Emcure Pharmaceuticals shares listed on NSE and BSE with a 31% premium to the IPO price, marking a strong market debut for the drugmaker.
Emcure Pharmaceuticals' consolidated net profit rose 28.81% in the March 2026 quarter; full-year profit climbed 35.67% to Rs 924.36 crore…
EPS 12.30 vs est. 12.63
Missed estimates by 2.57%
EPS 14.17 vs est. 10.91
Beat estimates by 29.90%
Emcure Pharmaceuticals Ltd received a 'No Action Indicated' classification from the FDA for its Gujarat manufacturing facility after an i…
EPS 12.85 vs est. 12.12
Beat estimates by 6.02%
Emcure Pharmaceuticals shares surged 8% following a partnership with Novo Nordisk to launch Poviztra®, a weight-loss drug in India, makin…
Dividend of ₹3.00 per share
Ex-date corporate action
Price returns
Historical performance
Technicals
Indicator consensus